Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Clinical trial NCT00456508 · COMPLETED

Trial details

NCT number: NCT00456508
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2007-04-01
Primary completion: 2010-06-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.